Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells

Clinical and Experimental Metastasis

Volumn 28, Issue 5, 2011, Pages 479-491

  Wedel, Steffen ^a   Hudak, Lukasz ^a   Seibel, Jens Michael ^a   Makarević, Jasmina ^a   Juengel, Eva ^a   Tsaur, Igor ^a   Wiesner, Christoph ^a   Haferkamp, Axel ^a   Blaheta, Roman A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Adhesion; Invasion; Prostate carcinoma; RAD001; Valproic acid

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; COLLAGEN; EVEROLIMUS; FIBRONECTIN; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; LAMININ; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN KINASE B; S6 KINASE; VALPROIC ACID;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MALE; METASTASIS INHIBITION; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

CELL ADHESION; CELL MOVEMENT; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; SIROLIMUS; STRUCTURE-ACTIVITY RELATIONSHIP; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 79955521269     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9386-8     Document Type: Article

References (38)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
2. JF Ward JW Moul 2005 Rising prostate-specific antigen after primary prostate cancer therapy Nat Clin Pract Urol 2 174 182 16474760 10.1038/ncpuro0145 (Pubitemid 40823138)
3. M Han AW Partin CR Pound, et al. 2001 Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience Urol Clin North Am 28 555 565 11590814 10.1016/S0094-0143(05)70163-4 1:STN:280:DC%2BD3Mrktlaluw%3D%3D (Pubitemid 32916759)
4. L Wang X Zou AD Berger, et al. 2009 Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA Am J Transl Res 1 62 71 19966939 1:CAS:528: DC%2BD1MXhtFejs7jI
5. W Weichert A Röske V Gekeler, et al. 2008 Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy Br J Cancer 98 604 610 18212746 10.1038/sj.bjc.6604199 1:CAS:528:DC%2BD1cXhs1Krsbo%3D (Pubitemid 351214528)
6. K Halkidou L Gaughan S Cook, et al. 2004 Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer Prostate 59 177 189 15042618 10.1002/pros.20022 1:CAS:528:DC%2BD2cXktl2lsLo%3D (Pubitemid 38481229)
7. CL Kremer RR Klein J Mendelson, et al. 2006 Expression of mTOR signaling pathway markers in prostate cancer progression Prostate 66 1203 1212 16652388 10.1002/pros.20410 1:CAS:528:DC%2BD28XosFCjurk%3D (Pubitemid 44175342)
8. B Dai YY Kong DW Ye, et al. 2009 Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics BJU Int 104 1009 1016 19389013 10.1111/j.1464-410X.2009.08538.x 1:CAS:528:DC%2BD1MXht1ylt7bP
9. R Bedolla TJ Prihoda JI Kreisberg, et al. 2007 Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation Clin Cancer Res 13 3860 3867 17606718 10.1158/1078-0432.CCR-07-0091 1:CAS:528:DC%2BD2sXntFymtr0%3D (Pubitemid 47037592)
10. Y Shimizu T Segawa T Inoue, et al. 2007 Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men BJU Int 100 685 690 17542985 10.1111/j.1464-410X.2007. 07014.x (Pubitemid 47205471)
11. A Angelucci P Muzi L Cristiano, et al. 2008 Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma Prostate 68 588 598 18288684 10.1002/pros.20708 1:CAS:528:DC%2BD1cXms1Wisro%3D (Pubitemid 351614637)
12. S Shabbeer MS Kortenhorst S Kachhap, et al. 2007 Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo Prostate 67 1099 1110 17477369 10.1002/pros.20587 1:CAS:528:DC%2BD2sXot1Kqtbs%3D (Pubitemid 46983339)
13. Q Xia J Sung W Chowdhury, et al. 2006 Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo Cancer Res 66 7237 7244 16849572 10.1158/0008-5472.CAN-05-0487 1:CAS:528:DC%2BD28XmvFGktbw%3D (Pubitemid 44197704)
14. TM Morgan TE Pitts TS Gross, et al. 2008 RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid Prostate 68 861 871 18361409 10.1002/pros.20752 1:CAS:528:DC%2BD1cXnsVKkt78%3D (Pubitemid 351845217)
15. A Schayowitz G Sabnis VC Njar, et al. 2008 Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro Mol Cancer Ther 7 121 132 18202015 10.1158/1535-7163.MCT-07-0581 1:CAS:528:DC%2BD1cXmsVyhsQ%3D%3D
16. M Iiizumi S Mohinta S Bandyopadhyay, et al. 2007 Tumor-endothelial cell interactions: therapeutic potential Microvasc Res 74 114 120 17498748 10.1016/j.mvr.2007.04.002 1:CAS:528:DC%2BD2sXht1ykur7O (Pubitemid 350051022)
17. CL Hall J Dai KL van Golen, et al. 2006 Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone Cancer Res 66 8648 8654 16951179 10.1158/0008-5472.CAN-06-1544 1:CAS:528:DC%2BD28XovF2iurY%3D (Pubitemid 44449180)
18. S Van Slambrouck AR Jenkins AE Romero, et al. 2009 Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer Int J Oncol 34 1717 1726 19424590
19. JM Liu J Bignon F Haroun-Bouhedja, et al. 2005 Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin Anticancer Res 25 2129 2133 16158954 1:CAS:528:DC%2BD2MXmtl2hur0%3D (Pubitemid 40904614)
20. Chao WT, Kunz J (2009) Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins. FEBS Lett 583:1337-1343
21. A Oertl B Relja J Makarevic, et al. 2006 Altered expression of beta1 integrins in renal carcinoma cell lines exposed to the differentiation inducer valproic acid Int J Mol Med 18 347 354 16820945 1:CAS:528:DC%2BD28XotFKhu7c%3D
22. M Björkman K Iljin P Halonen, et al. 2008 Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer Int J Cancer 123 2774 2781 18798265 10.1002/ijc.23885
23. O Nagakawa T Akashi Y Hayakawa, et al. 2004 Differential expression of integrin subunits in DU-145/AR prostate cancer cells Oncol Rep 12 837 841 15375509 1:CAS:528:DC%2BD2cXovFaitrs%3D
24. DS Welsbie J Xu Y Chen, et al. 2009 Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer Cancer Res 69 958 966 19176386 10.1158/0008-5472.CAN-08-2216 1:CAS:528:DC%2BD1MXhtFOkur0%3D
25. JK Slack-Davis JT Parsons 2004 Emerging views of integrin signaling: implications for prostate cancer J Cell Biochem 91 41 46 14689580 10.1002/jcb.10665 1:CAS:528:DC%2BD2cXlvV2gsA%3D%3D
26. M Schmelz AE Cress KM Scott, et al. 2002 Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites Neoplasia 4 243 254 11988844 10.1038/sj.neo.7900223 1:CAS:528: DC%2BD38XksFGnu7g%3D (Pubitemid 34525256)
27. TH Lai YC Fong WM Fu, et al. 2008 Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins Prostate 68 1341 1353 18512729 10.1002/pros.20799 1:CAS:528:DC%2BD1cXhtFaqsbbO
28. X Wang AM Ferreira 2005 Shao Q et al. (2005) Beta3 integrins facilitate matrix interactions during transendothelial migration of PC3 prostate tumor cells Prostate 63 65 80 15468167 10.1002/pros.20168 1:CAS:528: DC%2BD2MXjtFWiu7g%3D (Pubitemid 40365391)
29. S Balasubramanian D Kuppuswamy 2003 RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells J Biol Chem 278 42214 42224 12909616 10.1074/jbc.M303428200 1:CAS:528:DC%2BD3sXot1amtbg%3D (Pubitemid 37310488)
30. M Priulla A Calastretti P Bruno, et al. 2007 Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase Prostate 67 782 789 17373720 10.1002/pros.20566 1:CAS:528:DC%2BD2sXmtV2rtro%3D (Pubitemid 46711024)
31. HM Verheul B Salumbides K Van Erp, et al. 2008 Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors Clin Cancer Res 14 3589 3597 18519793 10.1158/1078-0432.CCR-07-4306 1:CAS:528:DC%2BD1cXmslygt7s%3D
32. D Mahalingam EC Medina JA Esquivel 2nd, et al. 2010 Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levels Clin Cancer Res 16 141 153 20028765 10.1158/1078-0432.CCR-09- 1385 1:CAS:528:DC%2BC3cXotFyk
33. L Taliaferro-Smith A Nagalingam D Zhong, et al. 2009 LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells Oncogene 28 2621 2633 19483724 10.1038/onc.2009.129 1:CAS:528:DC%2BD1MXms1aksL0%3D
34. CS Chen SC Weng PH Tseng, et al. 2005 Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes J Biol Chem 280 38879 38887 16186112 10.1074/jbc.M505733200 1:CAS:528:DC%2BD2MXht1SktLbP (Pubitemid 43853791)
35. E Ridolfi E Matteucci P Maroni, et al. 2008 Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs Br J Cancer 99 1623 1634 18941460 10.1038/sj.bjc.6604726 1:CAS:528: DC%2BD1cXhtlGrurrN
36. MC Lydolph M Morgan-Fisher AM Høye, et al. 2009 Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage Exp Cell Res 315 3312 3324 19796635 10.1016/j.yexcr.2009.09.022 1:CAS:528:DC%2BD1MXhtlGisrfE
37. M Lakshman L Xu V Ananthanarayanan, et al. 2008 Dietary genistein inhibits metastasis of human prostate cancer in mice Cancer Res 68 2024 2032 18339885 10.1158/0008-5472.CAN-07-1246 1:CAS:528:DC%2BD1cXjtFOht7w%3D (Pubitemid 351416590)
38. MR Russell WL Jamieson NG Dolloff A Fatatis 2009 The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells Oncogene 28 412 421 18850002 10.1038/onc.2008.390 1:CAS:528:DC%2BD1MXosVWruw%3D%3D